{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:08:19Z","timestamp":1790611699134,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR10867\/MED\/30\/1419\/2014"],"award-info":[{"award-number":["BT\/PR10867\/MED\/30\/1419\/2014"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010476","name":"Tata Memorial Centre","doi-asserted-by":"publisher","award":["900117"],"award-info":[{"award-number":["900117"]}],"id":[{"id":"10.13039\/501100010476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85160-6","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:42:21Z","timestamp":1736304141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR"],"prefix":"10.1038","volume":"15","author":[{"given":"Duhita","family":"Mirikar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Prabhash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv Kumar","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanita","family":"Naronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. S.","family":"Pramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Karimundackal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Rane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3807-1858","authenticated-orcid":false,"given":"Ranjan","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"85160_CR1","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1056\/NEJMra0707704","volume":"358","author":"F Ciardiello","year":"2008","unstructured":"Ciardiello, F. & Tortora, G. EGFR antagonists in cancer treatment. N Engl. J. Med. 358, 1160\u20131174 (2008).","journal-title":"N Engl. J. Med."},{"key":"85160_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ceb.2008.12.010","volume":"21","author":"NE Hynes","year":"2009","unstructured":"Hynes, N. E. & MacDonald, G. ErbB receptors and signaling pathways in cancer. Curr. Opin. Cell. Biol. 21, 177\u2013184 (2009).","journal-title":"Curr. Opin. Cell. Biol."},{"key":"85160_CR3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"50","author":"TJ Lynch","year":"2004","unstructured":"Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib. N Engl. J. Med. 50, 2129\u20132139 (2004).","journal-title":"N Engl. J. Med."},{"key":"85160_CR4","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497\u20131500 (2004).","journal-title":"Science"},{"key":"85160_CR5","first-page":"67","volume":"4","author":"EL Stewart","year":"2015","unstructured":"Stewart, E. L., Tan, S. Z., Liu, G. & Tsao, M. S. Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations\u2014A review. Transl Lung Cancer Res. 4, 67\u201381 (2015).","journal-title":"Transl Lung Cancer Res."},{"key":"85160_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ccr.2006.12.017","volume":"11","author":"CH Yun","year":"2007","unstructured":"Yun, C. H. et al. Structures of lung cancer\u2013derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell. 11, 217\u2013227 (2007).","journal-title":"Cancer Cell."},{"key":"85160_CR7","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1200\/JCO.2007.12.1178","volume":"26","author":"A Kumar","year":"2008","unstructured":"Kumar, A., Petri, E. T., Halmos, B. & Boggon, T. J. Structure and clinical relevance of the epidermal growth factor receptor in human cancer. J. Clin. Oncol. 26, 1742\u20131751 (2008).","journal-title":"J. Clin. Oncol."},{"key":"85160_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1126\/science.1101637","volume":"305","author":"R Sordella","year":"2004","unstructured":"Sordella, R., Bell, D. W., Haber, D. A. & Settleman, J. Gefitinib-sensitizing EGFR mutations in lung cancer activate antiapoptotic pathways. Science 305, 1163\u20131167 (2004).","journal-title":"Science"},{"key":"85160_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.lungcan.2009.04.021","volume":"67","author":"M Tiseo","year":"2010","unstructured":"Tiseo, M. et al. Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markers. Lung Cancer. 67, 355\u2013360 (2010).","journal-title":"Lung Cancer"},{"key":"85160_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","volume":"32","author":"LA Diaz Jr","year":"2014","unstructured":"Diaz, L. A. Jr & Bardelli, A. Liquid biopsies: genotyping circulating tumor DNA. J. Clin. Oncol. 32, 579\u2013586 (2014).","journal-title":"J. Clin. Oncol."},{"key":"85160_CR11","doi-asserted-by":"publisher","first-page":"e000292","DOI":"10.1136\/esmoopen-2017-000292","volume":"3","author":"Y Seki","year":"2018","unstructured":"Seki, Y. et al. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression. ESMO Open. 3, e000292 (2018).","journal-title":"ESMO Open."},{"key":"85160_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.lungcan.2013.08.014","volume":"82","author":"A Vallee","year":"2013","unstructured":"Vallee, A. et al. Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients. Lung Cancer. 82, 373\u2013374 (2013).","journal-title":"Lung Cancer"},{"key":"85160_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/CCO.0000000000000267","volume":"28","author":"A Buder","year":"2016","unstructured":"Buder, A., Tomuta, C. & Filipits, M. The potential of liquid biopsies. Curr. Opin. Oncol. 28, 130\u2013134 (2016).","journal-title":"Curr. Opin. Oncol."},{"key":"85160_CR14","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1158\/1078-0432.CCR-13-2482","volume":"20","author":"GR Oxnard","year":"2014","unstructured":"Oxnard, G. R. et al. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. Clin. Cancer Res. 20, 1698\u20131705 (2014).","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"85160_CR15","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1001\/jamaoncol.2016.0173","volume":"2","author":"AG Sacher","year":"2016","unstructured":"Sacher, A. G. et al. Prospective validation of rapid plasma genotyping for the detection of EGFR and KRAS mutations in advanced lung cancer. JAMA Oncol. 2(8), 1014\u20131022 (2016).","journal-title":"JAMA Oncol."},{"issue":"6","key":"85160_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jtho.2018.02.014","volume":"13","author":"A Buder","year":"2018","unstructured":"Buder, A. et al. Cell-free plasma DNA-guided treatment with osimertinib in patients with advanced EGFR-mutated NSCLC. J. Thorac. Oncol. 13(6), 821\u2013830 (2018).","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"85160_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5858\/arpa.2017-0388-CP","volume":"142","author":"NI Lindeman","year":"2018","unstructured":"Lindeman, N. I. et al. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the study of Lung Cancer, and the Association for Molecular Pathology. Arch. Pathol. Lab. Med. 142(3), 321\u2013346 (2018).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"18","key":"85160_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21037\/atm.2017.07.10","volume":"5","author":"AP Singh","year":"2017","unstructured":"Singh, A. P., Li, S. & Cheng, H. Circulating DNA in EGFR-mutated lung cancer. Ann. Transl Med. 5(18), 379\u2013379 (2017).","journal-title":"Ann. Transl Med."},{"issue":"7","key":"85160_CR19","doi-asserted-by":"publisher","first-page":"12501","DOI":"10.18632\/oncotarget.13915","volume":"8","author":"N Normanno","year":"2017","unstructured":"Normanno, N., Denis, M. G., Thress, K. S., Ratcliffe, M. & Reck, M. Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer. Oncotarget 8(7), 12501\u201312516 (2017).","journal-title":"Oncotarget"},{"issue":"2","key":"85160_CR20","first-page":"2191","volume":"18","author":"C Jing","year":"2018","unstructured":"Jing, C. et al. Next-generation sequencing-based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her2 and TP53 mutations in patients with non-small cell lung cancer. Mol. Med. Rep. 18(2), 2191\u20132197 (2018).","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"85160_CR21","doi-asserted-by":"publisher","first-page":"913","DOI":"10.5858\/arpa.2014-0095-OA","volume":"139","author":"KK Deeb","year":"2015","unstructured":"Deeb, K. K., Hohman, C. M., Risch, N. F., Metzger, D. J. & Starostik, P. Routine clinical mutation profiling of non\u2013small cell Lung Cancer using next-generation sequencing. Arch. Pathol. Lab. Med. 139(7), 913\u2013921 (2015).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"85160_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1756-9966-29-132","volume":"29","author":"G Ellison","year":"2010","unstructured":"Ellison, G. et al. A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples. J. Exp. Clin. Can. Res. 29, 132\u2013139 (2010).","journal-title":"J. Exp. Clin. Can. Res."},{"issue":"10","key":"85160_CR23","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jtho.2016.05.036","volume":"11","author":"M Reck","year":"2016","unstructured":"Reck, M. et al. ctDNA determination of EGFR mutation status in European and Japanese patients with advanced NSCLC: the ASSESS study. J. Thorac. Oncol. 11(10), 1682\u20131689 (2016).","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"85160_CR24","first-page":"2905","volume":"15","author":"Y Zhu","year":"2018","unstructured":"Zhu, Y. et al. A novel ARMS-based assay for the quantification of EGFR mutations in patients with lung adenocarcinoma. Oncol. Lett. 15(3), 2905\u20132912 (2018).","journal-title":"Oncol. Lett."},{"issue":"7","key":"85160_CR25","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.21037\/jtd.2019.07.42","volume":"11","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Comprehensive analysis of EGFR T790M detection by ddPCR and ARMS-PCR and the effect of mutant abundance on the efficacy of osimertinib in NSCLC patients. J. Thorac. Dis. 11(7), 3004\u20133014 (2019).","journal-title":"J. Thorac. Dis."},{"key":"85160_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/CMAR.S148134","volume":"10","author":"Q Feng","year":"2018","unstructured":"Feng, Q. et al. A comparison of QuantStudio 3D digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patients. Cancer Manag Res. 10, 115\u2013121 (2018).","journal-title":"Cancer Manag Res."},{"key":"85160_CR27","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1073\/pnas.1133470100","volume":"100","author":"D Dressman","year":"2003","unstructured":"Dressman, D., Yan, H., Traverso, G., Kinzler, K. W. & Vogelstein, B. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc. Nat. Acad. Sci. 100, 8817\u20138822 (2003).","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"2","key":"85160_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.advms.2021.06.003","volume":"66","author":"A Szpechcinski","year":"2021","unstructured":"Szpechcinski, A. et al. Detection of EGFR mutations in liquid biopsy samples using allele-specific quantitative PCR: a comparative real-world evaluation of two popular diagnostic systems. Adv. Med. Sci. 66(2), 336\u2013342 (2021).","journal-title":"Adv. Med. Sci."},{"issue":"7","key":"85160_CR29","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.21037\/tlcr-21-530","volume":"10","author":"K Guo","year":"2021","unstructured":"Guo, K. et al. Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I\u2013III non-small cell lung cancer (NSCLC) patients with baseline tissue EGFR mutations. Transl Lung Can. Res. 10(7), 3213\u20133225 (2021).","journal-title":"Transl Lung Can. Res."},{"key":"85160_CR30","doi-asserted-by":"publisher","first-page":"20848","DOI":"10.1038\/s41598-023-48210-5","volume":"13","author":"O Yamaguchi","year":"2023","unstructured":"Yamaguchi, O. et al. Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib. Sci. Rep. 13, 20848 (2023).","journal-title":"Sci. Rep."},{"key":"85160_CR31","doi-asserted-by":"publisher","first-page":"7808","DOI":"10.1158\/1078-0432.CCR-11-1712","volume":"17","author":"K Taniguchi","year":"2011","unstructured":"Taniguchi, K. et al. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas. Clin. Can. Res. 17, 7808\u20137815 (2011).","journal-title":"Clin. Can. Res."},{"key":"85160_CR32","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","volume":"14","author":"F Diehl","year":"2008","unstructured":"Diehl, F. et al. Circulating mutant DNA to assess tumor dynamics. Nat. Med. 14, 985\u2013990 (2008).","journal-title":"Nat. Med."},{"key":"85160_CR33","unstructured":"Altman, D. G. Practical Statistics for Medical Research (Chapman & Hall\/CRC, 1999)."},{"key":"85160_CR34","doi-asserted-by":"publisher","first-page":"16368","DOI":"10.1073\/pnas.0507904102","volume":"102","author":"F Diehl","year":"2005","unstructured":"Diehl, F. et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc. Natl. Acad. Sci. USA. 102, 16368\u201316373 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"85160_CR35","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/oxfordjournals.molbev.a026420","volume":"17","author":"KJ Fryxell","year":"2000","unstructured":"Fryxell, K. J. & Zuckerkandl, E. Cytosine deamination plays a primary role in the evolution of mammalian isochores. Mol. Biol. Evol. 17, 1371\u20131383 (2000).","journal-title":"Mol. Biol. Evol."},{"key":"85160_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev-genet-102108-134205","volume":"43","author":"JK Zhu","year":"2009","unstructured":"Zhu, J. K. Active DNA demethylation mediated by DNA glycosylases. Ann. Rev. Genet. 43, 143\u2013166 (2009).","journal-title":"Ann. Rev. Genet."},{"key":"85160_CR37","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1038\/sj.onc.1205996","volume":"21","author":"HE Krokan","year":"2002","unstructured":"Krokan, H. E., Drablos, F. & Slupphaug, G. Uracil in DNA: occurrence, consequences and repair. Oncogene 21, 8935\u20138948 (2002).","journal-title":"Oncogene"},{"key":"85160_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.dnarep.2006.10.014","volume":"6","author":"B Kavli","year":"2007","unstructured":"Kavli, B., Otterlei, M., Slupphaug, G. & Krokan, H. E. Uracil in DNA: general mutagen, but normal intermediate in acquired immunity. DNA Repair. (Amst). 6, 505\u2013516 (2007).","journal-title":"DNA Repair. (Amst)"},{"key":"85160_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1755-8794-7-23","volume":"7","author":"SQ Wong","year":"2014","unstructured":"Wong, S. Q. et al. CANCER 2015 Cohort sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med. Genomics. 7, 23 (2014).","journal-title":"BMC Med. Genomics"},{"key":"85160_CR40","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1158\/1078-0432.CCR-13-3114","volume":"20","author":"R Bourgon","year":"2014","unstructured":"Bourgon, R. et al. High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing. Clin. Can. Res. 20, 2080\u20132091 (2014).","journal-title":"Clin. Can. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85160-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T03:05:27Z","timestamp":1736305527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85160-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85160"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85160-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ACTREC-TMC institutional review board, and all participants provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"1252"}}